Board likely to raise Rs 200,00,00,000 via QIP after 3:1 bonus share: Multibagger penny stock Rs 86.56 hit 20 per cent upper circuit and saw volume breakout
The stock gave multibagger returns of 2,120 per cent in 3 years and a whopping 11,000 per cent in 5 years.
Today, shares of Remedium Lifecare Ltd hit 20 per cent upper circuit to an intraday high of Rs 86.56 from its previous closing of Rs 72.14. The stock’s 52-week high is Rs 179.66 and its 52-week low is Rs 58.50. The shares of the company saw a volume breakout of more than 5 times on BSE.
Remedium Lifecare Ltd informed that the meeting of the Board of Directors of the company is scheduled to be held on Monday, July 08, 2024, inter alia to:
1) Consider and approve the proposal for fundraising through Qualified Institutional Placement (QIP):
- To evaluate and approve the proposal to raise funds to Rs 200,00,00,000 by way of issuance of equity shares, convertible securities, or other eligible instruments to Qualified Institutional Buyers (QIBs) to finance the acquisition of Good Manufacturing Practices (GMP) assets in the Active Pharmaceutical Ingredients (API) and Intermediates space, as well as the acquisition of technology, Intellectual Property (IP), including US Drug Master File (USDMF), Certificate of Suitability to the Monographs of the European Pharmacopoeia (CEP), tech packages, and other relevant assets.
- To determine the quantum, terms, and conditions of the QIP, including but not limited to the pricing, tinting, and other relevant aspects of the issuance.
- To discuss and authorise the engagement of necessary intermediaries, including investment bankers, legal advisors, and other professionals for the QIP process.
2) Consider allotment of bonus shares to the equity shareholders of the company as on record date. The company's board proposed a bonus share issue in a ratio of 3:1, meaning for every 1 existing share you hold, you will receive 3 additional fully paid shares (1 rupee each) on the record date set for July 6, 2024 and ex-date is July 05, 2024.
3) Consider any other matter with the approval of the board.
Also Read: 1:1 Bonus Share: LIC-backed multibagger penny stock at Rs 4.07; Board allots 15,36,24,538 fully paid-up rights equity shares
Additionally, the company has been awarded a significant contract by Aster Biotech Limited, a pharmaceutical distribution company based in the United Kingdom. This multi-year deal signifies a major opportunity for Remedium to supply various pharmaceutical products to the UK market. The contract spans three years, from July 2024 to June 2027. Notably, the first year alone holds substantial value, with supplies of Active Pharmaceutical Ingredients (APIs), Intermediates, and Specialty Chemicals estimated at Rs 175 crore. This international contract positions Remedium well for continued growth and strengthens its presence in the global pharmaceutical supply chain.
Remedium Lifecare Ltd, founded in 1988, is a pharmaceutical company that is a middleman for other drug manufacturers. They buy and sell active pharmaceutical ingredients (APIs), which are the core chemicals used in medications, and intermediate chemicals needed to produce those APIs. Remedium deals with both innovative and generic drug companies, supplying them with a variety of products including cholesterol reducers, antidepressants, asthma medications, and allergy medicine ingredients. They source and sell these materials from around the world
Remedium Lifecare Ltd has a market cap of over Rs 800 crore with a 3-year stock price CAGR of 190 per cent. The company reported a total income of Rs 1,411.40 crore in Q4FY24 compared to a total income of Rs 75.58 crore in Q4FY23, an increase of 1,768 per cent. The company reported a net loss of Rs 53.72 crore in Q4FY24 compared to a net loss of Rs 4.78 crore in Q4FY23. In its annual results, the company reported total income increased by 698 per cent to Rs 4,062.80 crore and net profit increased by 504 per cent to Rs 32.72 crore in FY24 compared to FY23.
According to the shareholding pattern, the company's promoters own only a 1.11 per cent stake in the company. In FY24, FIIs took a fresh entry and bought a 0.04 per cent stake in the company and the maximum stake is owned by the public shareholders i.e. 98.85 per cent stake. The company's shares have an ROE of 123 per cent and an ROCE of 100 per cent. The stock gave multibagger returns of 2,120 per cent in 3 years and a whopping 11,000 per cent in 5 years. Investors should keep an eye on this micro-cap stock.
Disclaimer: The article is for informational purposes only and not investment advice.
DSIJ's ‘Penny Pick’ service provides research-backed penny stock recommendations below Rs. 100. If this interests you, do download the service details here.
Related articles
-
Multibagger heavy electrical equipment stock at Rs 2.29 hit 10 per cent upper circuit on July 02 with spurt in volume by more than 4 times on BSE
-
Only buyers in this multibagger penny stock at Rs 2.24; hit upper circuit today - PAT zooms over 900 per cent to Rs 547 lakh!
-
19,000 per cent returns & PAT zooms over 4,400 per cent: Multibagger micro-cap stock hit 20 per cent upper circuit as it announces stock split – know the record date inside
-
Penny stock at Rs 22 and promoters sold 3,03,39,541 shares: This micro-cap company bags new orders worth Rs 69.33 crore from various clients across India
-
40 per cent in just 2 days: Dheeraj Lohia bought 4,50,000 shares of this multibagger penny stock; scrip hit upper circuit and 52-week high!
-
From Rs 3.83 to Rs 9.20 per share: Multibagger micro-cap logistics stock gains 140 per cent in just 283 days, scrip hit back-to-back upper circuit!
-
Upper Circuit & 52-week high alert: Heavy buying in this multibagger penny stock under Rs 10; PAT zooms 280 per cent!
-
Dolly Khanna gains Rs 39,00,673 from this multibagger penny stock in just 1 day; scrip hit upper circuit & 52-week high!
-
Promoters of the company bought 1,70,00,000 shares & FIIs bought 80,00,000 shares of this multibagger penny stock; scrip hit upper circuit!
-
Multibagger penny stock below Rs 10 with 1,000 per cent returns hit upper circuit; PAT zooms over 200 per cent & FIIs increase stake – Do you own it?
-
FII-bought 1,00,00,000 shares of the multibagger penny stock with Rs 361 crore order book; scrip hit upper circuit & PAT zooms 270 per cent!
-
LIC-backed penny stock with 1,650 per cent returns: This micro-cap company signs MoU with Philips Corporation, USA – know more here!
-
Upper Circuit Alert: Heavy buying witnessed in this penny stock under Rs 35 following conversion of partly paid-up equity shares into fully paid-up equity shares!
-
Back-to-back upper circuits: Heavy buying witnessed in this multibagger penny stock; Company bags orders from Indian Railways!
-
1000-per cent returns in this multibagger penny stock: Board announces bonus shares; hit back-to-back upper circuits & 52-week high!
-
Multibagger penny stock under Rs 10 with 1,275 per cent returns: This micro-cap company reports a 246 per cent jump in net profit!
-
Mukul Agrawal gains Rs 40,43,00,000 from this multibagger penny stock under Rs 40 in just 2 days with 1,613 MW order book; hit upper circuit & 52-week high!
-
2,200 per cent returns in this multibagger penny stock below Rs 10: This micro-cap company reports a 71 per cent jump in net profit!
-
4,800 per cent returns in this multibagger penny stock under Rs 40: This micro-cap company bags new order worth Rs 2,70,02,653.65 from Central Railway!
-
Multibagger penny stock below Rs 10: This micro-cap company receives export orders worth Rs 20,00,00,000; scrip hit upper circuit!